Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996..

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons..

Expert consensus document on management of cardiovascular diseases during pregnancy..

Recommendations for the management of patients after heart valve surgery..

Heart diseases in pregnancy..

Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infektiösen Endokarditis (Neuauflage 2009)..

Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology..

Changing mortality in congenital heart disease..

CEMACH. CEMACH Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood safer—2003-2005: The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: Centre for Maternal and Child Enquiries; 2008..

Hypertensive disorders of pregnancy..

Maternal heart disease and pregnancy outcome: a single-centre experience..

Prospective multicenter study of pregnancy outcomes in women with heart disease..

Peripartum cardiomyopathy: National Heart..

Pregnancy-induced changes in pharmacokinetics: a mechanisticbased approach..

Combined Doppler and echocardiographic measurement of cardiac output: theory and application in pregnancy..

Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study..

Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee..

Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study..

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)..

Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication..

Clinical exercise testing..

The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks..

Number 299, September 2004 (replaces No. 158..

Implications of ICRP 60 and the patient directive 97/43 Euratom for nuclear medicine..

Conceptus radiation dose and risk from cardiac catheter ablation procedures..

Fetal doses from radiological examinations..

Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations..

MR procedures: biologic effects, safety, and patient care..

A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus..

ACR guidance document for safe MR practices: 2007..

Peripartum versus idiopathic dilated cardiomyopathy in young women—a comparison of clinical, pathologic and prognostic features..

Ablation of severe drug-resistant tachyarrhythmia during pregnancy..

A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease..

Pregnancy related complications in women with hypertrophic cardiomyopathy..

American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram..

Signore C, Spong C, Freeman RK, Ramin S, Barss VA. Overview of fetal assessment. Uptodate 2010. Disponible en: http://www.uptodate.com/contents/overview-offetal-assessment..

Doppler ultrasound for fetal assessment in high risk pregnancies..

Fetal biophysical profile..

Cardiac surgery during pregnancy..

The problem of cardiac valve prostheses, anticoagulants, and pregnancy..

Intracardiac surgery in pregnant women..

Predictors of neonatal outcome in early-onset placental dysfunction..

Cardiopulmonary bypass during pregnancy..

Cardiac surgery in the parturient..

ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Develop Guidelines for the Management of Adults with Congenital Heart Disease)..

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists..

Perloff JK CJ. Congenital Heart Disease in Adults. 2.a e.d. Filadelfia: WB Saunders; 1998..

Mechanisms of hemostasis at cesarean delivery..

Cardiovascular problems in pregnant women with the Marfan syndrome..

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology..

A Swan-Ganz catheter related complication in a patient with Eisenmenger's syndrome..

Practical management of the parturient with congenital heart disease..

Bonica JJ, McDonald JS. Principles and practice of obstetric analgesia and anesthesia. 2.a ed. Baltimore: Williams & Wilkins; 1994..

Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the puerperium..

Foley M, Lockwood C, Gersh B, Barss V. Maternal cardiovascular and hemodynamic adaptation to pregnancy. Uptodate. 2010. Disponible en: http://www.uptodate.com/contents/maternal-cardiovascular-and-hemodynamic-adaptations-to-pregnancy..

Outcome of pregnancy in women with congenital heart disease: a literature review..

Predictors of pregnancy complications in women with congenital heart disease..

Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia..

Incessant atrial tachycardia accelerated by pregnancy..

Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes..

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death— executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society..

Acute myocardial infarction following oral methyl-ergometrine intake..

Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section..

Valvular heart disease and pregnancy part I: native valves..

Endocarditis during pregnancy..

Pregnancy in patients with heart disease: experience with 1,000 cases..

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)..

ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease..

Prevention of bacterial endocarditis..

Bertsche T, Haas M, Oberwittler H, Haefeli WE, Walter-Sack I. [Drugs during pregnancy and breastfeeding: new risk categories—antibiotics as a model]. Dtsch Med Wochensch. 2006; 131:1016-22..

Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in der Schwangerschaft und Stillzeit. Vol 7. Múnich: Urban & Fischer; 2006..

Risks of contraception and pregnancy in heart disease..

Jastrow N, Meyer P, Khairy P, Mercier LA, Dore A, Marcotte F, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol. 2010;Jul 24.[Epub ahead of print]..

Cardiac outcomes after pregnancy in women with congenital heart disease..

Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease..

Pregnancy outcomes in women with congenital heart disease..

Congenital heart disease in adolescents and adults. Pregnancy and contraception..

Family planning requirements in the adult congenital heart disease clinic..

The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement..

Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study..

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee..

ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol. 2006; 108:225-34..

Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis..

A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy..

Effect of prostaglandin E2 and F2alpha on the systemic and pulmonary circulation in pregnant anesthetized women..

Predicting deep venous thrombosis in pregnancy: out in ‘LEFt’ field?..

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?..

Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996..

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)..

Oakley C, Warnes CA, editores. Heart Disease in Pregnancy. 2.a ed. Oxford: Wiley-Blackwell; 2007..

Pregnancy in cyanotic congenital heart disease..

Three live-birth pregnancies in a woman with Williams syndrome..

Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries..

Pregnancy after atrial repair for transposition of the great arteries..

Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect..

Atrial septal defects in the adult: recent progress and overview..

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline..

Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect..

Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects..

Outcome of pregnancy in patients after repair of aortic coarctation..

Coarctation of the aorta: outcome of pregnancy..

The effect of valvular heart disease on maternal and fetal outcome of pregnancy..

Noncardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis..

Effect of pulmonary stenosis on pregnancy outcomes—a case-control study..

Second natural history study of congenital heart defects..

Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract..

Congenital aortic stenosis in adults: rate of progression and predictors of clinical outcome..

Aortic dissection in pregnancy: importance of pregnancy-induced changes in the vessel wall and bicuspid aortic valve in pathogenesis..

Aortic dissection in pregnancy: analysis of risk factors and outcome..

Outcomes of pregnancy in women with tetralogy of Fallot..

Pregnancy outcome and Ebstein's anomaly..

Ebstein's anomaly: outcome of pregnancy..

Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries..

Pregnancy outcomes in women with transposition of the great arteries and arterial switch operation..

Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries..

Right ventricular dysfunction in congenitally corrected transposition of the great arteries..

Pregnancy and delivery in women after Fontan palliation..

Pregnancy outcomes after the Fontan repair..

Long-term outcome and quality of life in adult patients after the Fontan operation..

Histopathologic findings in human aortic media associated with pregnancy..

Pregnancy and aortic root growth in the Marfan syndrome: a prospective study..

Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD)..

Aortic dissection during pregnancy: treatment by emergency cesarean section immediately followed by operative repair of the aortic dissection..

Maternal and fetal complications of pregnancy in the Marfan syndrome..

Management of grown up congenital heart disease..

Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the Management of Adults with Congenital Heart Disease—Part II..

Maternal complication of pregnancy in Marfan syndrome..

Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation..

Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type..

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial..

Aortic dilatation and dissection in Turner syndrome..

The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis..

Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis..

Anesthetic management of the pregnant patient with Marfan syndrome..

Clinical and echocardiographic assessment of pregnant women with valvular heart diseases—maternal and fetal outcome..

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice..

Cardiac risk in pregnant women with rheumatic mitral stenosis..

Early and intermediateterm outcomes of pregnancy with congenital aortic stenosis..

Risk of complications during pregnancy in women with congenital aortic stenosis..

Gender differences in clinical presentation and surgical outcome of aortic stenosis..

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)..

Percutaneous balloon aortic valvuloplasty during pregnancy: use of the Inoue balloon and the physiologic antegrade approach..

Valvular heart disease and pregnancy: part II: prosthetic valves..

Outcome of pregnancy in women after pulmonary autograft valve replacement for congenital aortic valve disease..

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature..

Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin..

Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy..

Anticoagulation in pregnant women with prosthetic heart valves..

Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin..

Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience..

Use of low molecular weight heparin in pregnant women with mechanical heart valves..

A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation..

Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy..

Pregnancy with prosthetic heart valves—30 years’ nationwide experience in Denmark..

Vitamin K antagonists and pregnancy outcome. A multicentre prospective study..

Dosedependent fetal complications of warfarin in pregnant women with mechanical heart valves..

Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis..

Risk of warfarin during pregnancy with mechanical valve prostheses..

Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy..

Troponin I levels in patients with preeclampsia..

Acute myocardial infarction in pregnancy and the puerperium: a population-based study..

Acute myocardial infarction associated with pregnancy..

Acute myocardial infarction in pregnancy: a United States population-based study..

Antiphospholipid syndrome..

Thrombolytic therapy in pregnancy..

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a metaanalysis..

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy..

Peripartum cardiomyopathy..

Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients..

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy..

Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy..

Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy..

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology..

Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome..

Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis..

Haemostatic changes in pregnancy..

Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity..

Major congenital malformations after first-trimester exposure to ACE inhibitors..

Atenolol and fetal growth in pregnancies complicated by hypertension..

The blockade of mineralocorticoid hormone signaling provokes dramatic teratogenesis in cultured rat embryos..

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)..

Peripartum cardiomyopathy: a condition intensivists should be aware of..

Cardiac diseases..

Excretion of antihypertensive medication into human breast milk: a systematic review..

Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study..

Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy..

Pregnancy outcomes in women with dilated cardiomyopathy..

Management of hypertrophic cardiomyopathy..

Risk associated with pregnancy in hypertrophic cardiomyopathy..

Adenosine therapy for supraventricular tachycardia during pregnancy..

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary. a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society..

Ibutilide-induced cardioversion of atrial fibrillation during pregnancy..

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)..

Sex-based differences in the effect of digoxin for the treatment of heart failure..

Digitalislike immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay..

Characteristics of new-onset ventricular arrhythmias in pregnancy..

Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia..

Implantable cardioverterdefibrillators and pregnancy: a safe combination?..

Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome..

Therapeutic guidelines for congenital complete heart block presenting in pregnancy..

Maternal complete heart block in pregnancy: analysis of four cases and review of management..

Management of hypertension before, during, and after pregnancy..

Report on high blood pressure in pregnancy..

Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome?..

The natural history of white coat hypertension during pregnancy..

Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension..

Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis..

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESHESC Task Force on the Management of Arterial Hypertension..

Seventh report of the Joint National Committee on Prevention, Detection..

Report of the Canadian Hypertension Society Consensus Conference: 1..

Outcome of infants delivered between 24 and 28 weeks’ gestation in women with severe pre-eclampsia..

Fetal outcome in trial of antihypertensive treatment in pregnancy..

Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children..

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems..

Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil..

Antiplatelet agents for preventing pre-eclampsia and its complications..

The impact of maternal obesity on maternal and fetal health..

A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy..

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis..

Treatment of hypertensive complications in pregnancy..

Bromocriptine related atypical vascular accidents postpartum identified through medicolegal reviews..

Pregnancy-induced hypertension: recurrence rate in second pregnancies..

Risks of hypertensive disorders in the second pregnancy..

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study..

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study..

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses..

Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a Guideline from the American Heart Association..

Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada..

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study..

Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series..

Deep venous thrombosis and pulmonary embolism in pregnancy..

Maternal mortality in Australia, 1973-1996..

Antenatal pulmonary embolism: risk factors, management and outcomes..

Safety of withholding heparin in pregnant women with a history of venous thromboembolism..

Reducing the Risk of Thrombosis And Embolism During Pregnancy and the Puerperium..

Venous thromboembolic disease and pregnancy..

A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study..

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women..

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy..

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)..

Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review..

D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed..

A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy..

Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT..

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133 (6 Suppl):S844-86..

Use of thrombolytics for the treatment of thromboembolic disease during pregnancy..

Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options..

Minor transplacental passage of fondaparinux in vivo..

Hypertension management: the care gap between clinical guidelines and clinical practice..

Antihypertensive drugs in pregnancy..

American Academy of Pediatrics Committee on Drugs: the transfer of drugs and other chemicals into human milk..